Randomized double-blind placebo-controlled study in patients with atopic dermatitis
Randomized double-blind placebo-controlled study in patients with atopic dermatitis
Randomized Double-blind Placebo-controlled Study of KHK4577 in Patients With Atopic Dermatitis
This study is an randomized double-blind placebo-controlled study to evaluate the efficacy and the safety of oral KHK4577 for 6 weeks in patients with atopic dermatitis. Pharmacokinetics of KHK4577 will also be assessed.
100 项与 KHK-4577 相关的专利(医药)